A crossover trial in 20 type 2 diabetes patients testing whether a six-week soy-protein, isoflavone and cotyledon-fibre supplement (Abalon) affected cardiovascular risk markers, blood glucose and insulin.
Citation: Hermansen K, Søndergaard M, Høie L, Carstensen M, Brock B. Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 2001;24:228–233.
